McCulloch, R., Iyengar, S., Okosun, J., Bishton, M., Vidyadhar, V., Prodger, C., Broom, A., Phillips, N., Preston, G., Shah, N., Walter, H., Ahearne, M., Lowry, L., Austen, B., Singh, A., Turner, A., Dutton, D., Heague, M., Cahil, T., Maybury, B., Jamil, F., Crosbie, N., Gibb, A., Ogilvie, C., Walewska, R., Hmaid, A., Wolf, J., Dunning, L., Willan, J., Macheta, M., Lewis, D., Lambert, J., Wilson, M., Eyre, T. (2025). TP53 aberrant Mantle Cell Lymphoma treated with first-line systemic therapy: A real-world analysis of outcomes in 120 patients treated in the United Kingdom. Blood. https://doi.org/10.1182/blood-2025-1827